Homozygous-BECN1-deficient mice exhibit embryonic lethality, while heterozygous disruption of BECN1 leads to the occurrence of lung cancer, liver cancer, lymphoma and mammary tumor [4, 5]. This evidence concerns the gene BECN1 and breast cancer.